Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: Bioequivalence Minocycline Bioequivalence [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the bioequivalence of minocycline formulations for acne has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Infections (Acne) | Phase 1 | Status: COMPLETED